Robots vs. surgeons: which is better for hysterectomy?
NCT ID NCT05613816
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compared robot-assisted laparoscopy using the Senhance Surgical System to conventional laparoscopy for hysterectomy and other uterine surgeries. Researchers measured operating time, blood loss, and safety in 78 patients. The goal was to see if the robot offers advantages over standard minimally invasive surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Senhance Surgical System (robot-assisted surgical device)
- What this could lead to
- If successful, this could show that robot-assisted surgery is as safe and efficient as conventional laparoscopy, potentially offering surgeons more precision.
- What could go wrong
- This is a small, completed observational study, not a randomized trial, so results may not apply broadly. The robot may not improve outcomes or could increase costs.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital Tuebingen, Department of Women's Health
Tübingen, 72076, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Can an antiviral make radiation more effective against cervical cancer?
- What raises endometrial cancer risk in black women? a study digs in
- Can a hormone drug shrink painful ovarian cysts better than the pill?
- A One-Two punch against cervical cancer: testing plus vaccination in HIV-Positive women
- Can a Two-Antibody combo outsmart advanced cancer?